Gene Biotech Co., Ltd. (086060) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Gene Biotech Co., Ltd. (086060:KRX), powered by AI.

Current Price
₩3,895
P/E Ratio
8.9
Market Cap
33.5B
Sector
Common Stock
What is the Gene Biotech Co., Ltd. stock price forecast?

Gene Biotech Co., Ltd. is currently trading at ₩3,895. View real-time AI analysis on Alpha Lenz.

What is Gene Biotech Co., Ltd. insider trading activity?

View the latest insider trading data for Gene Biotech Co., Ltd. on Alpha Lenz.

What is Gene Biotech Co., Ltd.'s P/E ratio?

Gene Biotech Co., Ltd.'s P/E ratio is 8.9.

Gene Biotech Co., Ltd.

KRX · 086060
₩3,895+5(+0.13%)Market closedKRX regular session 09:00–15:30 KST
Ask about Gene Biotech Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Gene Biotech Co., Ltd. trades at a P/E of 8.9 (undervalued) with modest ROE of 7.2%.

Ask for details

Company Overview

Gene Biotech Co., Ltd. is a biotechnology company specializing in the research, development, and commercialization of bio-based products. Its primary function is to harness genetic engineering and biotechnology to create applications in the health and pharmaceutical industries. Notable features of Gene Biotech include its focus on developing innovative solutions for genetic therapies, DNA analysis tools, and bioengineering products that can advance healthcare treatments and diagnostic capabilities. The company plays a significant role in the pharmaceutical sector by offering cutting-edge technologies that address unmet medical needs and improve patient outcomes. Its contributions to the biotech sphere are critical, as it helps facilitate the next generation of medical solutions, thereby impacting public health and safety globally. Gene Biotech Co., Ltd.'s research initiatives and product pipelines position it as a key player in the biotechnology market, with a strong emphasis on sustainable and effective therapeutic development.

CEO이찬호
SectorCommon Stock
IndustryCommon Stock
0

Company Statistics

FY 2025

Profile

₩33,538,236,365Market Cap
₩90,788,971,770Revenue
8.61MShares Out
0Employees

Margins

15.85%Gross
7.02%EBITDA
4.40%Operating
4.86%Pre-Tax
4.17%Net

Valuation

8.85P/E
0.61P/B
0.37EV/Sales
6.11EV/EBITDA
8.70P/FCF

Growth (CAGR)

3.14%Rev 3Yr
8.96%Rev 5Yr
32.43%Op Inc 3Yr
19.23%Op Inc 5Yr
35.49%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

5.13%ROA
7.15%ROE
6.74%ROIC

Financial Health

₩9,587,355,150Cash & Cash Equivalents
₩11,050,427,780Net Debt
37.53%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Gene Biotech Co., Ltd. (ticker: 086060) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $33.5B.

The current price is ₩3,895 with a P/E ratio of 8.85x and P/B of 0.61x.

ROE is 7.15% and operating margin is 4.40%. Annual revenue is $90.8B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Gene Biotech Co., Ltd. (086060) Stock Forecast 2026 ₩3,895 — Price, Financials & Analyst Targets | Alpha Lenz